- Report
- March 2025
- 92 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- July 2024
- 136 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- March 2025
- 173 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- July 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2025
- 83 Pages
United States
From €3340EUR$3,500USD£2,799GBP
- Report
- November 2024
- 100 Pages
Brazil
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2024
- 125 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 126 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- August 2023
- 97 Pages
North America
From €2815EUR$2,950USD£2,359GBP
- Report
- August 2023
- 186 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- August 2023
- 106 Pages
Global
From €2815EUR$2,950USD£2,359GBP
- Report
- August 2023
- 104 Pages
Europe
From €3293EUR$3,450USD£2,759GBP
- Book
- May 2015
- 656 Pages
- Book
- June 2022
North America
- Book
- June 2020
North America
- Book
- March 2022
North America

Bovine Respiratory Disease (BRD) is a complex of respiratory illnesses that affect cattle. It is the most common and costly disease in the animal healthcare/veterinary industry. BRD is caused by a combination of viral and bacterial pathogens, and is spread through direct contact with infected animals, contaminated feed, and airborne transmission. Clinical signs of BRD include fever, coughing, nasal discharge, and difficulty breathing. Treatment of BRD typically involves antibiotics, anti-inflammatory drugs, and supportive care. Vaccines are also available to help prevent the disease.
The BRD market is highly competitive, with a range of products and services available to veterinarians and farmers. Companies in the market include Boehringer Ingelheim, Merck Animal Health, Zoetis, Elanco, and Bayer Animal Health. Show Less Read more